Zobrazeno 1 - 5
of 5
pro vyhledávání: '"M. S., Dolima"'
Publikováno v:
Perspectives in Clinical Research, Vol 2, Iss 3, Pp 86-89 (2011)
Context: Though India has been thought to be an ideal destination for conduct of clinical drug trials, other smaller countries seem to be doing better. The pace of growth observed during 2005-2009 seems to be plateaued in 2010. Aims: There is an urge
Externí odkaz:
https://doaj.org/article/a5fee00396f84ef48fb97019fbf0ec6a
Publikováno v:
Perspectives in Clinical Research, Vol 2, Iss 2, Pp 64-66 (2011)
Background: Type 2 diabetes mellitus (Type 2 DM) has been recognized as the recent pandemic; India and China competing each other for the title--"Diabetes Capital of the World." A number of new drugs have been recently available and has lead to a boo
Externí odkaz:
https://doaj.org/article/eadb1c7c0f1b4766afdc7dde20fcb19d
Publikováno v:
Perspectives in Clinical Research, Vol 2, Iss 2, Pp 64-66 (2011)
Perspectives in Clinical Research
Perspectives in Clinical Research
Background: Type 2 diabetes mellitus (Type 2 DM) has been recognized as the recent pandemic; India and China competing each other for the title--Diabetes Capital of the World. A number of new drugs have been recently available and has lead to a boom
Publikováno v:
Perspectives in Clinical Research, Vol 2, Iss 3, Pp 86-89 (2011)
Perspectives in Clinical Research
Perspectives in Clinical Research
Context: Though India has been thought to be an ideal destination for conduct of clinical drug trials, other smaller countries seem to be doing better. The pace of growth observed during 2005-2009 seems to be plateaued in 2010. Aims: There is an urge
Publikováno v:
Perspectives in Clinical Research; 2011, Vol. 2 Issue 3, p86-89, 4p